Document:

EX-10.6

 Exhibit 10.6 

Restricted Stock Agreement 

under the YWX Holdings, Inc. 

2014 Stock Option and Grant Plan 
  

			
	 Name of Grantee:
	  	                                 (the
“Grantee”)
	 No. of Shares:
	  	                        Shares of Common Stock
	 Grant Date:
	  	                    , 20     (the “Grant Date”)
	 Per Share Purchase Price:
	  	$                 (the “Per Share Purchase Price”)

 Pursuant to the YWX Holdings, Inc. 2014 Stock Option and Grant Plan (the “Plan”) and this
Restricted Stock Agreement (the “Agreement”), YWX Holdings, Inc., a Delaware corporation (together with all successors thereto, the “Company”), hereby grants, sells and issues to the individual named above, who is
an officer, employee, director, consultant or other key person of the Company or any of the Subsidiaries, the Shares (as defined below) at the Per Share Purchase Price, which represents the Fair Market Value per share on the Grant Date, subject to
the terms and conditions set forth herein and in the Plan. The Grantee agrees to the provisions set forth herein and acknowledges that each such provision is a material condition of the Company’s agreement to issue and sell the Shares to him or
her. The Company hereby acknowledges receipt of $         in full payment for the Shares. All references to share prices and amounts herein shall be equitably adjusted to reflect stock splits, stock
dividends, recapitalizations, mergers, reorganizations and similar changes affecting the capital stock of the Company, and any shares of capital stock of the Company received on or in respect of Shares in connection with any such event (including
any shares of capital stock or any right, option or warrant to receive the same or any security convertible into or exchangeable for any such shares or received upon conversion of any such shares) shall be subject to this Agreement on the same basis
and extent at the relevant time as the Shares in respect of which they were issued, and shall be deemed Shares as if and to the same extent they were issued at the date hereof. 

1. Definitions. For the purposes of this Agreement, the following terms shall have the following respective
meanings. All capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Plan. 
 An
“Affiliate” of any Person means a Person that directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common control with the first mentioned Person. A Person shall be deemed to control
another Person if such first Person possesses directly or indirectly the power to direct, or cause the direction of, the management and policies of the second Person, whether through the ownership of voting securities, by contract or otherwise. 

“Bankruptcy” shall mean (i) the filing of a voluntary petition under any bankruptcy or insolvency law, or a petition for
the appointment of a receiver or the making of an assignment for the benefit of creditors, with respect to the Grantee or any Permitted Transferee, or (ii) the Grantee or any Permitted Transferee being subjected involuntarily to such a petition
or assignment or to an attachment or other legal or equitable interest with respect to the Grantee’s or the Permitted Transferee’s assets, which involuntary petition or assignment or attachment is not discharged within 60 days after its
date. 
 “Cause” shall have the meaning set forth in the Employment Agreement[, dated the date hereof,] between the Company
and Grantee (the “Employment Agreement”). 

 “Common Stock” shall mean the Company’s Common Stock, par value $0.001 per
share, together with any shares into which Common Stock may be converted or exchanged, as provided above and herein. 
 “Good
Reason” shall have the meaning set forth in the Employment Agreement. 
 “Permitted Transferees” shall mean any of
the following to whom the Grantee may transfer Shares hereunder (as set forth in Section 4): the Grantee’s spouse, children (natural or adopted), stepchildren or a trust for their sole benefit of which the Grantee is the settlor or any
entity in which such persons or trusts are the sole owners; provided, however, that any such trust does not require or permit distribution of any Shares during the term of this Agreement unless subject to its terms. Upon the death of
the Grantee (or a Permitted Transferee to whom shares have been transferred hereunder), the term Permitted Transferees shall also include such deceased Grantee’s (or such deceased Permitted Transferee’s) estate, executions,
administrations, personal representations, heirs, legatees and distributees, as the case may be. 
 “Person” shall mean any
individual, corporation, partnership (limited or general), limited liability company, limited liability partnership, association, trust, joint venture, unincorporated organization or any similar entity. 

“Restricted Shares” shall initially mean all of the Shares being purchased by the Grantee on the date hereof, provided
that on each of the dates listed below, the respective number of Shares indicated below shall become Vested Shares if Grantee remains an employee on each such date. 
  

			
	 Incremental
 (Aggregate Number)

of Vested Shares
	 	 Vesting Date

	25%	 	1 Year Anniversary of Grant Date
	2.083%	 	Per Month Thereafter
	100%	 	4 Year Anniversary of Grant Date

 For the avoidance of doubt, all Restricted Shares shall be deemed fully vested and exercisable on the four year anniversary of
the Grant Date. 
 If the Grantee’s employment with the Company or the Company’s successor entity is terminated by the Company without Cause
within 12 months of the consummation of such Sale Event, then the remaining Restricted Shares held by the Grantee or any Permitted Transferee shall vest and be deemed Vested Shares upon the date of such termination. 

“Sale Event” shall mean, regardless of form thereof, consummation of (i) the dissolution or liquidation of the Company,
(ii) the sale of all or substantially all of the assets of the Company on a consolidated basis to an unrelated person or entity, (iii) a merger, reorganization or consolidation in which the outstanding shares of Stock are converted into or
exchanged for securities of the successor entity and the holders of the Company’s outstanding voting power immediately prior to such transaction do not own a majority of the outstanding voting power of the successor entity immediately upon
completion of such transaction, (iv) the sale of all or a majority of the outstanding capital stock of the Company to an unrelated person or entity or (v) any other transaction in which the owners of the Company’s outstanding voting
power immediately prior to such transaction do not own at least a majority of the outstanding voting power of the successor entity immediately upon completion of the transaction, in each case where the consideration received by the holders of Stock
in connection with such event consists of cash, freely tradable public securities, or some combination thereof. 

  
 2 

 “Shares” shall mean the number of shares of Common Stock being purchased by the
Grantee on the date hereof and any additional shares of Common Stock or other securities received in respect of the Shares, as a dividend on, or otherwise on account of, the Shares. 

“Termination Event” shall mean the termination of the Grantee’s employment with the Company and its Subsidiaries for any
reason whatsoever, regardless of the circumstances thereof, and including without limitation upon death, disability, retirement or discharge or resignation for any reason, whether voluntary or involuntary. For purposes hereof, the determination of
the reason for termination of the Grantee’s employment shall be made in accordance with the provisions of the Employment Agreement. Upon a Termination Event, the Grantee shall cease to vest in any Restricted Shares. 

“Vested Shares” shall mean all Shares which are not Restricted Shares. 

2. Purchase and Sale of Shares; Investment Representations. 

(a) Purchase and Sale. On the date hereof, the Company hereby sells to the Grantee, and the Grantee hereby purchases from the Company,
the number of Shares set forth above for the Per Share Purchase Price. 
 (b) Investment Representations. In connection with the
purchase and sale of the Shares contemplated by Section 2(a) above, the Grantee hereby represents and warrants to the Company as follows: 

(i) The Grantee is purchasing the Shares for the Grantee’s own account for investment only, and not for resale or with a
view to the distribution thereof. 
 (ii) The Grantee has had such an opportunity as he or she has deemed adequate to obtain
from the Company such information as is necessary to permit him or her to evaluate the merits and risks of the Grantee’s investment in the Company and has consulted with the Grantee’s own advisers with respect to the Grantee’s
investment in the Company. 
 (iii) The Grantee has sufficient experience in business, financial and investment matters to be
able to evaluate the risks involved in the purchase of the Shares and to make an informed investment decision with respect to such purchase. 

(iv) The Grantee can afford a complete loss of the value of the Shares and is able to bear the economic risk of holding such
Shares for an indefinite period. 
 (v) The Grantee understands that the Shares are not registered under the Act (it being
understood that the Shares are being issued and sold in reliance on the exemption provided in Rule 701 thereunder) or any applicable state securities or “blue sky” laws and may not be sold or otherwise transferred or disposed of in the
absence of an effective registration statement under the Act and under any applicable state securities or “blue sky” laws (or exemptions from the registration requirements thereof). The Grantee further acknowledges that certificates
representing the Shares will bear restrictive legends reflecting the foregoing. 

  
 3 

 3. Repurchase Right. 

(a) Repurchase. Upon the occurrence of a Termination Event or the Bankruptcy of the Grantee, the Company or its assigns shall have the
right and option to repurchase all or any portion of the Shares held by the Grantee or any Permitted Transferee as of the date of such Termination Event or Bankruptcy. In addition, upon the Bankruptcy of any of the Grantee’s Permitted
Transferees, the Company or its assigns shall have the right and option to repurchase all or any portion of the Shares held by such Permitted Transferee as of the date of such Bankruptcy. The purchase and sale arrangements contemplated by the
preceding sentences of this Section 3(a) are referred to herein as the “Repurchase.” 
 (b) Repurchase Price. The per
share purchase price of the Shares subject to the Repurchase (the “Repurchase Price”) shall be, subject to adjustment as provided above (i) in the case of Shares which are Vested Shares as of the date of the event giving rise
to the Repurchase, the Fair Market Value of such Vested Shares as of such date as determined by the Board, and (ii) in the case of Restricted Shares, the Per Share Purchase Price; provided, however, if the Termination Event is a
termination by the Company for Cause (including, for the avoidance of doubt, any termination which the Board determines after such termination is for Cause), then the Repurchase Price for all Vested Shares and Restricted Shares shall be the lesser
of (1) the Per Share Purchase Price and (2) the Fair Market Value. The Repurchase Right with respect to Vested Shares shall terminate in accordance with Section 10(b). Notwithstanding the foregoing, in the event that Grantee or his or her
estate or authorized representative disputes the Board’s determination of Fair Market Value pursuant to this Section 3(b), such Person shall deliver written notice thereof, together with such Person’s calculation of fair market value of
the Vested Shares subject to repurchase, to the Company within fourteen (14) days after being notified of the Board’s determination. The Company and Grantee (or his or her estate or authorized representative) shall use commercially
reasonable efforts for a period of thirty (30) days to resolve any such dispute. If such dispute is not resolved within such thirty (30)-day period, the Board shall select a nationally recognized
investment banking firm reasonably acceptable to Grantee (or his or her estate or authorized representative) (the “Valuation Firm”) to determine the fair market value of the Vested Shares subject to repurchase for purposes of this
Section 3(a). The determination of the Valuation Firm shall be equal to the position of the Company or the position of Grantee (or his or her estate or authorized representative) or between the position of the Company and the position of
Grantee (or his or her estate or authorized representative) and shall be final and binding upon the parties (including Grantee’s estate or authorized representative). The fees and expenses of the Valuation Firm shall be paid one-half by the Company and one-half by the Grantee. 
 (c)
Closing Procedure. The Company or its assigns shall effect the Repurchase (if so elected) by delivering or mailing to the Grantee (and/or, if applicable, any Permitted Transferees) written notice within six (6) months after the
Termination Event or Bankruptcy, specifying a date within such six-month period in which the Repurchase shall be effected. Upon such notification, the Grantee and any Permitted Transferees shall promptly
surrender to the Company any certificates representing the Shares being purchased, together with a duly executed stock power for the transfer of such Shares to the Company or the Company’s assignee or assignees. Upon the Company’s or its
assignee’s receipt of the certificates from the Grantee or any Permitted Transferees, the Company or its assignee or assignees shall deliver to him, her or them a check for the Repurchase Price of the Shares being purchased, provided,
however, that the Company may pay the Repurchase Price for such shares by offsetting and canceling any indebtedness then owed by the Grantee to the Company. At such time, the Grantee and/or any holder of the Shares shall deliver to the
Company the certificate or certificates representing the Shares so repurchased, duly endorsed for transfer, free and clear of any liens or encumbrances. The Repurchase right specified herein shall survive and remain in effect as to Restricted Shares
following and notwithstanding any public offering by or merger or other transaction involving the Company and certificates representing such Restricted Shares shall bear legends to such effect, subject to Section 10(b) below. 

  
 4 

 4. Restrictions on Transfer of Shares. None of the Shares shall be
sold, assigned, transferred, pledged, hypothecated, given away or in any other manner disposed of or encumbered, other than by operation of law, unless such transfer (i) has been approved by the Board of Directors of the Company and (b) is
in compliance with all applicable securities laws (including, without limitation, the Act), and such disposition is in accordance with the terms and conditions of Sections 3 and 4 and such disposition does not cause the Company to become subject to
the reporting requirements of the Securities Exchange Act of 1934, as amended. In connection with any such transfer of Shares, the Company may require the transferor to provide at the Grantee’s own expense an opinion of counsel to the
transferor, satisfactory to the Company, that such transfer is in compliance with all foreign, federal and state securities laws (including, without limitation, the Act). Any attempted disposition of Shares not in accordance with the terms and
conditions of Sections 3 and 4 shall be null and void, and the Company shall not reflect on its records any change in record ownership of any Shares as a result of any such disposition, shall otherwise refuse to recognize any such disposition and
shall not in any way give effect to any such disposition of any Shares. Subject to the foregoing general provisions, Shares may be transferred pursuant to the following specific terms and conditions: 

(a) Transfers to Permitted Transferees. The Grantee may sell, assign, transfer or give away any or all of the Shares to Permitted
Transferees; provided, however, that such Permitted Transferee(s) shall, as a condition to any such transfer, agree to be subject to the provisions of this Agreement to the same extent as the Grantee (including, without limitation, the
provisions of Sections 3, 4, 9 and 10) and shall have delivered a written acknowledgment to that effect to the Company. Further, the Grantee or any Permitted Transferee pursuant to this Section 4, may be required to enter into certain
agreements as are reasonably requested by the Company, including but not limited to a stockholders agreement or similar agreement, prior to receipt of the Shares. 

(b) Transfers Upon Death. Upon the death of the Grantee, any Shares then held by the Grantee at the time of such death and any Shares
acquired thereafter by the Grantee’s legal representative pursuant to this Agreement shall be subject to the provisions of this Agreement to the same extent as the Grantee (including, without limitation, the provisions of Sections 3, 4, 9 and
10, if applicable), and the Grantee’s estate, executors, administrators, personal representatives, heirs, legatees and distributees shall be obligated to convey such Shares to the Company or its assigns under the terms contemplated hereby. 

(c) Company’s Right of First Refusal. In the event that the Grantee (or any Permitted Transferee holding Shares subject to this
Section 4(c)) desires to sell or otherwise transfer all or any part of the Shares (other than to a Permitted Transferee), the Grantee (or Permitted Transferee) first shall give written notice to the Company of the Grantee’s (or Permitted
Transferee’s) intention to make such transfer. Such notice shall state the number of Shares which the Grantee (or Permitted Transferee) proposes to sell (the “Offered Shares”), the price and the terms at which the proposed sale is to
be made and the name and address of the proposed transferee. At any time within 30 days after the receipt of such notice by the Company, the Company or its assigns may elect to purchase all or any portion of the Offered Shares at the price and on
the terms offered by the proposed transferee and specified in the notice. The Company or its assigns shall exercise this right by mailing or delivering written notice to the Grantee (or Permitted Transferee) within the foregoing 30-day period. If the Company or its assigns elect to exercise its purchase rights under this Section 4(c), the closing for such purchase shall, in any event, take place within 45 days after the receipt by the
Company of the initial notice from the Grantee (or Permitted Transferee). In the event that the Company or its assigns do not elect to exercise such purchase right, or in the event that the Company or its assigns do not pay the full purchase price
within such 45-day 

  
 5 

 
period, the Grantee (or Permitted Transferee) may, within 60 days thereafter, sell the Offered Shares to the proposed transferee and at the same price and on the same terms as specified in the
Grantee’s (or Permitted Transferee’s) notice. Any Shares purchased by such proposed transferee shall no longer be subject to the terms of this Agreement. Any Shares not sold to the proposed transferee shall remain subject to this
Agreement. Notwithstanding the foregoing, the restrictions under this Section 4(c) shall terminate in accordance with Section 10(b). 

5. Legend. Any certificate(s) representing the Shares shall carry substantially the following legend: 

“The transferability of this certificate and the shares of stock represented hereby are subject to the restrictions, terms
and conditions (including repurchase and restrictions against transfers) contained in a certain Restricted Stock Agreement between the Company and the holder of this certificate (a copy of which is available at the offices of the Company for
examination).” 
 “The shares represented by this certificate have not been registered under the Securities Act of
1933 or the securities laws of any state. The shares may not be sold or transferred in the absence of such registration or an exemption from registration.” 

6. Escrow Arrangement. 

(a) Escrow. In order to carry out the provisions of Sections 3 and 4 of this Agreement more effectively, the Company shall hold the
Shares in escrow together with separate stock powers executed by the Grantee in blank for transfer, and any Permitted Transferee shall, as an additional condition to any transfer of Shares, execute a like stock power as to such Shares. The Company
shall not dispose of the Shares except as otherwise provided in this Agreement. In the event of any repurchase by the Company (or any of its assigns), the Company is hereby authorized by the Grantee and any Permitted Transferee, as the
Grantee’s and each such Permitted Transferee’s attorney-in-fact, to date and complete the stock powers necessary for the transfer of the Shares being purchased
and to transfer such Shares in accordance with the terms hereof. At such time as any Shares are no longer subject to any repurchase, first refusal or drag along rights contained herein or in any other agreement applicable to the Shares, the Company
shall, at the written request of the Grantee, deliver to the Grantee (or the relevant Permitted Transferee) a certificate representing such Shares with the balance of the Shares (if any) to be held in escrow pursuant to this Section 6. 

(b) Remedy. Without limitation of any other provision of this Agreement or other rights, in the event that the Grantee, any Permitted
Transferees or any other person or entity is required to sell the Grantee’s Shares pursuant to the provisions of Section 3 and 4 of this Agreement and in the further event that he or she refuses or for any reason fails to deliver to the
designated purchaser of such Shares the certificate or certificates evidencing such Shares together with a related stock power, such designated purchaser may deposit the applicable purchase price for such Shares with a bank designated by the
Company, or with the Company’s independent public accounting firm, as agent or trustee, or in escrow, for the Grantee, any Permitted Transferees or other person or entity, to be held by such bank or accounting firm for the benefit of and for
delivery to him, her, them or it, and/or, in its discretion, pay such purchase price by offsetting any indebtedness then owed by the Grantee as provided above. Upon any such deposit and/or offset by the designated purchaser of such amount and upon
notice to the person or entity who was required to sell the Shares to be sold pursuant to the provisions of Section 3, 4 and 5, such Shares shall at such time be deemed to have been sold, assigned, transferred and conveyed to such purchaser,
the holder thereof shall have no further rights thereto (other than the right to withdraw the payment thereof held in escrow, if applicable), and the Company shall record such transfer in its stock transfer book or in any appropriate manner. 

  
 6 

 7. Withholding Taxes. The Grantee acknowledges and agrees that
the Company or any of its Subsidiaries have the right to deduct from payments of any kind otherwise due to the Grantee, or from the Shares held pursuant to Section 6 hereof, the minimum federal, state or local taxes of any kind required by law
to be withheld with respect to the purchase of the Shares by the Grantee. In furtherance of the foregoing the Grantee agrees to elect, in accordance with Section 83(b) of the Internal Revenue Code of 1986, as amended, to recognize ordinary income in
the year of acquisition of the Shares, and to pay to the Company all withholding taxes shown as due on his or her Section 83(b) election form, or otherwise ultimately determined to be due with respect to such election, based on the excess, if any,
of the Fair Market Value of such Shares as of the date of the purchase of such Shares by the Grantee over the purchase price for such Shares. 

8. Assignment. At the discretion of the Board, the Company shall have the right to assign the right to
exercise its rights with respect to the Repurchase or pursuant to Section 4 to any Person or Persons, in whole or in part in any particular instance, upon the same terms and conditions applicable to the exercise thereof by the Company, and such
assignee or assignees of the Company shall then take and hold any Shares so acquired subject to such terms as may be specified by the Company in connection with any such assignment. 

9. Drag Along Right. In the event the holders of a majority of the Company’s equity securities then
outstanding (the “Majority Shareholders”) determine to sell or otherwise dispose of all or substantially all of the assets of the Company or all or fifty percent (50%) or more of the capital stock of the Company in each case in a
transaction constituting a change in control of the Company, to any non-Affiliate(s) of the Company or any of the Majority Shareholders, or to cause the Company to merge with or into or consolidate with any non-Affiliate(s) of the Company or any of the Majority Shareholders (in each case, the “Buyer”) in a bona fide negotiated transaction (a “Sale”), the Grantee, including any
Permitted Transferees, shall be obligated to and shall upon the written request of a Majority Shareholders: (a) sell, transfer and deliver, or cause to be sold, transferred and delivered, to the Buyer, his or her Shares (including for this purpose
all of such Grantee’s or his or her Permitted Transferee’s Shares that presently or as a result of any such transaction may be acquired upon the exercise of options (following the payment of the exercise price therefor)) on substantially
the same terms applicable to the Majority Shareholders (with appropriate adjustments to reflect the conversion of convertible securities, the redemption of redeemable securities and the exercise of exercisable securities as well as the relative
preferences and priorities of preferred stock); and (b) execute and deliver such instruments of conveyance and transfer and take such other action, including voting such Shares in favor of any Sale proposed by the Majority Shareholders and
executing any purchase agreements, merger agreements, indemnity agreements, escrow agreements or related documents, as the Majority Shareholders or the Buyer may reasonably require in order to carry out the terms and provisions of this
Section 9; provided, however, that: 
 (a) the liability for indemnification, if any, of Grantee in the Sale and for the inaccuracy of
any representations and warranties made by the Company or its stockholders in connection with such Sale, is several and not joint with any other Person (except to the extent that funds may be paid out of an escrow established to cover breach of
representations, warranties and covenants of the Company as well as breach by any stockholder of any of identical representations, warranties and covenants provided by all stockholders), and is pro rata in proportion to, and does not exceed, the
amount of consideration paid to Grantee in connection with such Sale; 

  
 7 

 (b) liability shall be limited to Grantee’s applicable share (determined based on the
respective proceeds payable to each stockholder in connection with such Sale in accordance with the provisions of the Company’s certificate of incorporation) of a negotiated aggregate indemnification amount that applies equally to all
stockholders, except with respect to claims related to fraud or willful misconduct by Grantee, the liability for which need not be limited as to Grantee; 

(c) subject to the terms of the Company’s certificate of incorporation in effect immediately prior to the Sale (the
“Charter”), upon the consummation of the Sale, (i) each holder of each class or series of the Company’s stock will have the opportunity to receive the same form of consideration for their shares of such class or series as
is received by other holders in respect of their shares of such same class or series of stock and (ii) the aggregate consideration receivable by all holders of the Company’s capital stock shall be allocated in accordance with the Charter;
and 
 (d) subject to clause (c) above and the terms of the Charter, requiring the same form of consideration to be available to the
holders of any single class or series of capital stock, if any holders of any capital stock of the Company are given an option as to the form and amount of consideration to be received as a result of the Sale, all holders of such capital stock will
be given the same option; provided, however, that nothing in this Subsection 3.3(d) shall entitle any holder to receive any form of consideration that such holder would be ineligible to receive as a result of such holder’s failure to satisfy
any condition, requirement or limitation that is generally applicable to the Company’s stockholders. 
 For illustration purposes, the calculation of
the amount expected to be distributed to Grantee in connection with a Sale is set forth on Exhibit A. The obligations under this Section 9 shall terminate in accordance with Section 10(b). 

10. Miscellaneous Provisions. 

(a) Lockup provision. The Grantee and each Permitted Transferee shall agree, if requested by the Company and any underwriter engaged by
the Company, not to sell or otherwise transfer or dispose of any securities of the Company (including, without limitation pursuant to Rule 144 under the Act (or any successor or similar exemptive rule hereafter in effect)) held by them for such
period following the effective date of any registration statement of the Company filed under the Act as the Company or such underwriter shall specify reasonably and in good faith, not to exceed 180 days in the case of the Company’s Initial
Public Offering or 90 days in the case of any other public offering. 
 (b) Termination. The Company’s Repurchase right with
respect to Vested Shares under Section 3 shall terminate upon the closing of the Company’s Initial Public Offering or upon consummation of any Sale Event, in either case as a result of which shares of the Company (or successor entity) of
the same class as the Shares are registered under Section 12 of the Exchange Act of 1934 and publicly traded on NASDAQ/NMS or any national security exchange; provided, however, that all other provisions shall remain in effect
following the same until all of the Shares have become Vested Shares. 
 (c) Record Owner; Dividends. The Grantee and any Permitted
Transferees, during the duration of this Agreement, shall be considered the record owners of and shall be entitled to vote the Shares if and to the extent the Shares are entitled to voting rights. The Grantee and any Permitted Transferees shall be
entitled to receive all dividends and any other distributions declared on the Shares; provided, however, that the Company is under no duty to declare any such dividends or to make any such distribution. 

  
 8 

 (d) Equitable Relief. The parties hereto agree and declare that legal remedies are
inadequate to enforce the provisions of this Agreement and that equitable relief, including specific performance and injunctive relief, may be used to enforce the provisions of this Agreement. 

(e) Change and Modifications. This Agreement may not be orally changed, modified or terminated, nor shall any oral waiver of any of its
terms be effective. This Agreement may be changed, modified or terminated only by an agreement in writing signed by the Company and the Grantee. 

(f) Governing Law. This Agreement shall be governed by and construed in accordance with the laws of Delaware without regard to conflict
of law principles. 
 (g) Headings. The headings are intended only for convenience in finding the subject matter and do not constitute
part of the text of this Agreement and shall not be considered in the interpretation of this Agreement. 
 (h) Saving Clause. If any
provision(s) of this Agreement shall be determined to be illegal or unenforceable, such determination shall in no manner affect the legality or enforceability of any other provision hereof. 

(i) Notices. All notices, requests, consents and other communications shall be in writing and be deemed given when delivered personally,
by telex or facsimile transmission or when received if mailed by first class registered or certified mail, postage prepaid. Notices to the Company or the Grantee shall be addressed as set forth underneath their signatures below, or to such other
address or addresses as may have been furnished by such party in writing to the other. Notices to any holder of the Shares other than the Grantee shall be addressed to the address furnished by such holder to the Company. 

(j) Benefit and Binding Effect. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto, their
respective successors, assigns, and legal representatives. Without limitation of the foregoing, upon any stock-for-stock merger in which the Company is not the surviving
entity, shares of the Company’s successor issued in respect of the Shares shall remain subject to vesting. The Company has the right to assign this Agreement, and such assignee shall become entitled to all the rights of the Company hereunder to
the extent of such assignment. 
 (k) Dispute Resolution. Any controversy, claim or dispute arising out of or relating to this
Agreement, shall be settled solely and exclusively by a binding arbitration process administered by JAMS/Endispute in Los Angeles, California. Such arbitration shall be conducted in accordance with the then-existing JAMS/Endispute Rules of Practice
and Procedure, with the following exceptions if in conflict: (i) one arbitrator who is a retired judge shall be chosen by JAMS/Endispute; (ii) the Company will pay the expenses and fees of the arbitrator, together with other expenses of
the arbitration incurred or approved by the arbitrator; and (iii) arbitration may proceed in the absence of any party if written notice (pursuant to the JAMS/Endispute rules and regulations) of the proceedings has been given to such party. Each
party shall bear its own attorneys fees and expenses; provided that the arbitrator may assess the prevailing party’s fees and costs against the non-prevailing party as part of the arbitrator’s award.
The parties agree to abide by all decisions and awards rendered in such proceedings. Such decisions and awards rendered by the arbitrator shall be final and conclusive. All such controversies, claims or disputes shall be settled in this manner in
lieu of any action at law or equity; provided, however, that nothing in this subsection shall be construed as precluding the bringing an action for injunctive relief or specific performance as provided in this Agreement. This dispute resolution
process and any arbitration hereunder shall be confidential and neither any party nor the neutral arbitrator shall disclose the existence, contents or results of such process without the prior written consent of all parties, except where necessary

  
 9 

 
or compelled in a court of competent jurisdiction to enforce this arbitration provision or an award from such arbitration or otherwise in a legal proceeding. If JAMS/Endispute no longer exists or
is otherwise unavailable, the parties agree that the American Arbitration Association (“AAA”) shall administer the arbitration in accordance with its then-existing rules. In such event, all references herein to JAMS/Endispute shall
mean AAA. Notwithstanding the foregoing, Executive and the Company each have the right to resolve any issue or dispute over intellectual property rights by court action instead of arbitration. 

(1) Counterparts. This Agreement may be executed in two or more counterparts, each of which when executed shall be deemed to be an
original, but all of which together shall constitute one and the same instrument. The exchange of copies of this Agreement and of signature pages by facsimile transmission or other electronic means shall constitute effective execution and delivery
of this Agreement as to the parties and may be used in lieu of the original Agreement for all purposes. The parties hereto may rely upon machine copies of signatures to this Agreement to the same extent as manually signed original signatures. 

[SIGNATURE PAGE FOLLOWS] 

  
 10 

 IN WITNESS WHEREOF, the Company and the Grantee have executed this Restricted Stock Agreement as
of the date first above written. 
  

			
	 COMPANY

	
	 YWX HOLDINGS, INC.

	
	
By:                  
                                         
                  

		 	 Name:

		 	 Title:

	
	 Address for Notice:

	 YWX Holdings, Inc.

c/o Great Hill Partners LLC

	 One Liberty Square

	 Boston, MA 02109

	 Attention: Laurie Gerber

	 Facsimile: (617) 292-9430

	 E-mail address:
lgerber@greathillpartners.com

	
	 And copies to:

	 Latham & Watkins, LLP

	 John Hancock Tower

	 200 Clarendon Street

	 Boston, MA 02116

	 Attention: Alexander B. Temel

	 Facsimile: (617) 948-6001

	 E-mail address:
alexander.temel@lw.com

  
 [Signature Page to
Restricted Stock Agreement] 

  

			
	GRANTEE:
	
	   

	Name:
	
	Address:
		
	  
	 	
	  
	 	
	  
	 	

  

	
	 [SPOUSE’S CONSENT
 I acknowledge that I
have read the foregoing Restricted Stock Agreement and understand the contents thereof.

	
	]

  
 [Signature Page to
Restricted Stock Agreement]EX-10.10

 Exhibit 10.10 

Employment Agreement 

This Employment Agreement (this “Agreement”), executed and delivered as of March 27, 2017, to be effective as of
January 1, 2017 (the “Effective Date”), is made by and between Whole Body, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Rosanna McCollough
(“Executive”) (collectively referred to herein as the “Parties”). Capitalized terms used but not otherwise defined in this Agreement shall have the meanings set forth in Section 10. 

RECITALS 
 WHEREAS, the Company
and the Executive desire to enter into this Agreement for the employment of the Executive by the Company upon the terms and subject to the conditions set forth herein. 

AGREEMENT 
 In
consideration of the respective covenants and agreements set forth below, the Parties hereto agree as follows: 
 1. Employment. 

(a) General. Effective as of the Effective Date, the Company shall employ Executive and Executive shall accept the employment by the
Company, for the period and in the position set forth in this Section 1, and upon the other terms and conditions herein provided. 

(b) Employment Term. The term of employment under this Agreement (the “Term”) shall be for the period beginning on the
Effective Date, and ending on the first anniversary thereof, subject to earlier termination as provided in Section 3. The Term shall automatically renew for additional one (1) year periods unless no later than ninety
(90) days prior to the end of the applicable Term either Party gives written notice of non-renewal (“Notice of Non-Renewal”) to the other, in which
case Executive’s employment will terminate at the end of the then-applicable Term or any other date set by the Company in accordance with Section 3) and subject to earlier termination as provided in
Section 3. 
 (c) Position and Duties. Executive shall serve as Chief Executive Officer and President of the
Company with such customary responsibilities, duties and authority as may from time to time be assigned to Executive by the Board of Directors of the Company (the “Board”). Executive shall devote substantially all of
Executive’s working time and efforts to the business and affairs of the Company (including service to its affiliates, if applicable), provided that Executive may engage in charitable, community service, religious, educational and industry
association activities as long as those activities do not interfere with Executive’s duties under this Agreement. Executive agrees to observe and comply with the rules and policies of the Company as adopted by the Company from time to time, in
each case as amended from time to time, as set forth in writing, and as delivered or made available to Executive (each, a “Policy” and, collectively, the “Policies”). 

2. Compensation and Related Matters. 

(a) Annual Base Salary. During the Term, Executive shall receive a base salary at a rate of Three Hundred Thousand Dollars ($300,000)
per annum (the “Annual Base Salary”), which shall be paid in accordance with the customary payroll practices of the Company. Such Annual Base Salary shall be reviewed (and may be adjusted) from time to time by the Board. 

 (b) Bonus. During the Term, the Executive will be eligible to participate in an incentive
program established by the Board. Executive’s bonus compensation under such incentive program shall be targeted at One Hundred Thousand Dollars ($100,000) each year to be awarded based on successfully delivering the goals set by the Board each
year during the Term, which may include such key metrics as the Company’s achievement of the consolidated revenue target, EBITDA target, visit target and a discretionary target. The Company may add additional bonus incentives for surpassing key
metric goals such as revenue and/or EBITDA. The Company shall use commercially reasonable efforts to set the incentive targets for a calendar year no later than January 31 of such year. The payment of any bonus pursuant to the incentive program
shall be subject to Executive’s continued employment with the Company through the date of payment which shall be no later than April 15 following the respective year end. Executive’s target annual bonus may be reviewed (and may be
adjusted) from time-to-time by the Board. 
 (c)
Benefits. During the Term, Executive shall be eligible to participate in all employee benefit plans, programs and arrangements of the Company, commensurate with Executive’s position as a senior executive and consistent with the terms
thereof and as such plans, programs and arrangements may be amended from time to time. The Company shall either pay the entire cost (i.e., one hundred percent (100%)) of all insurance premiums for Executive and her eligible dependents or pay the
full gross amount to Executive necessary to cover the entire cost for all insurance premiums for Executive and her eligible dependents. In no event shall Executive be eligible to participate in any severance plan or program of the Company, except as
set forth in Section 4 of this Agreement. 
 (d) Vacation. During the Term, Executive shall be entitled to accrue and use four
(4) weeks of paid vacation per year (pro-rated for any partial year of service), in accordance with the Company’s Policies; provided, however, that Executive shall not accrue any vacation time
in excess of eight (8) weeks (the “Accrual Limit”) and shall cease accruing vacation time if Executive’s accrued vacation reaches the Accrual Limit until such time as Executive’s accrued vacation drops below the
Accrual Limit. Any vacation shall be taken at the reasonable and mutual convenience of the Company and Executive, provided however, that any request of Executive to take paid vacation shall not be unreasonably denied by the Company. 

(e) Expenses. During the Term, the Company shall reimburse Executive for all reasonable travel and other business expenses incurred by
Executive in the performance of Executive’s duties to the Company in accordance with the Company’s expense reimbursement Policy (including, but not limited to, reimbursement for a cellular telephone (including hardware and usage fees), a
laptop computer, and membership fees/dues in any trade or professional association or organization as mutually agreed to by Executive and the Board. 

(f) Key Person Insurance. At any time during the Term, the Company shall have the right to insure the life of Executive for the
Company’s sole benefit. The Company shall have the right to determine the amount of insurance and the type of policy. Executive shall reasonably cooperate with the Company in obtaining such insurance by submitting to physical examinations, by
supplying all information reasonably required by any insurance carrier, and by executing all necessary documents reasonably required by any insurance carrier, provided that any information provided to an insurance company or broker shall not be
provided to the Company without the prior written authorization of Executive. Executive shall incur no financial obligation by executing any required document, and shall have no interest in any such policy. 

(g) Indemnification and Insurance. At all times during the Term, the Company shall hold and maintain adequate levels of Directors and
Officers liability insurance, and with provisions that will provide coverage for Executive as a director, officer, and employee of the Company or any affiliate. 

  
 2 

 Moreover, during the Term and thereafter, the Company shall indemnify Executive to the fullest extent provided by
law and the Company’s bylaws from and against any expense (including attorney’s fees), judgments, fines, penalties, and amounts paid in settlement incurred by Executive in connection with any proceeding in which Executive was or is made a
party or was or is involved by reason of the fact that Executive was or is employed by or serving as an employee, officer or director of the Company or any of its affiliates. 

3. Termination. 
 Executive’s
employment hereunder may be terminated by the Company or Executive, as applicable, without any breach of this Agreement under the following circumstances: 

(a) Circumstances. 

(i) Death. Executive’s employment hereunder shall terminate upon Executive’s death. 

(ii) Disability. If Executive has incurred a Disability, as defined below, the Company may terminate Executive’s
employment. 
 (iii) Termination for Cause. The Company may terminate Executive’s employment for Cause, as
defined below. 
 (iv) Termination without Cause. The Company may terminate Executive’s employment without Cause,
which shall include a termination of Executive as a result of the Company not renewing the Term pursuant to Section 1. 

(v) Resignation from the Company for Good Reason. Executive may resign Executive’s employment with the Company for
Good Reason, as defined below. 
 (vi) Resignation from the Company Without Good Reason. Executive may resign
Executive’s employment with the Company for any reason other than Good Reason or for no reason, which shall include a termination of Executive as a result of the Executive not renewing the Term pursuant to Section 1. 

(b) Notice of Termination. Any termination of Executive’s employment by the Company or by Executive under this Section 3
(other than termination pursuant to paragraph (a)(i)) shall be communicated by a written notice to the other party hereto (i) indicating the specific termination provision in this Agreement relied upon, (ii) setting forth in reasonable
detail the facts and circumstances claimed to provide a basis for termination of Executive’s employment under the provision so indicated, if applicable, and (iii) specifying a Date of Termination which, if submitted by Executive, shall be
at least thirty (30) days following the date of such notice (a “Notice of Termination”); provided, however, that in the event that Executive delivers a Notice of Termination to the Company, the Company may, in its sole
discretion, change the Date of Termination to any date that occurs following the date of Company’s receipt of such Notice of Termination and is prior to the date specified in such Notice of Termination; provided, further, that the
Company shall pay Executive her base salary and continue her benefits through the Date of Termination provided by Executive. A Notice of Termination submitted by the Company may provide for a Date of Termination on the date Executive receives the
Notice of Termination, or any date thereafter elected by the Company in its sole discretion. The failure by the Company to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Cause shall not waive any
right of the Company hereunder or preclude the Company from asserting such fact or circumstance in enforcing the Company’s rights hereunder. 

  
 3 

 (c) Company Obligations upon Termination. Upon termination of Executive’s employment
pursuant to any of the circumstances listed in Section 3, Executive (or Executive’s estate) shall be entitled to receive the sum of: (i) the portion of Executive’s Annual Base Salary earned through the Date
of Termination, but not yet paid to Executive; (ii) any expenses owed to Executive pursuant to Section 2(f); (iii) any accrued vacation; and (iv) any amount accrued and arising from Executive’s participation in, or benefits
accrued under any employee benefit plans, programs or arrangements, which amounts shall be payable in accordance with the terms and conditions of such employee benefit plans, programs or arrangements (collectively, the “Company
Arrangements”). Except as otherwise expressly required by law (e.g., COBRA) or as specifically provided herein, all of Executive’s rights to salary, severance, benefits, bonuses and other compensatory
amounts hereunder (if any) shall cease upon the termination of Executive’s employment hereunder. In the event that Executive’s employment is terminated by the Company for any reason, Executive’s sole and exclusive remedy shall be to
receive the severance payments and benefits described in this Section 3(c) or Section 4, as applicable. 

(d) Deemed Resignation. Upon termination of Executive’s employment for any reason, Executive shall be deemed to have resigned from
all offices and directorships, if any, then held with the Company or any of its affiliates. 
 4. Severance Payments. 

(a) Termination for Cause or Resignation from the Company Without Good Reason. If Executive’s employment shall terminate pursuant
to Section 3(a)(iii) for Cause or pursuant to Section 3(a)(vi) for Executive’s resignation from the Company without Good Reason, then Executive shall not be entitled to any severance payments or benefits, except as provided in
Section 3(c). 
 (b) Termination without Cause, Termination Upon Death or Disability, or Resignation from the Company for Good
Reason. 
 (i) If Executive’s employment shall terminate as a result of Executive’s death pursuant to Section
3(a)(i) or Disability pursuant to Section 3(a)(ii), without Cause pursuant to Section 3(a)(iv), or pursuant to Section 3(a)(v) due to Executive’s resignation for Good Reason, then, subject to Executive signing on or before the
twenty-first (21st) day (or forty-fifty (45th) day to the extent required by applicable law) following Executive’s Separation from Service
(as defined below), and not revoking, a release of claims in the form attached as Exhibit A to this Agreement (the “Release”), and Executive’s continued compliance with Sections 5 and 6, Executive shall receive,
in addition to payments and benefits set forth in Section 3(c), the following: 
 (A) an amount in cash equal to the
Annual Base Salary of Executive as of the Date of Termination, payable in the form of salary continuation in regular installments over the twelve- (12-) month period following the date of Executive’s
Separation from Service (the “Severance Period”) in accordance with the Company’s normal payroll practices; 

(B) in the event that the Date of Termination occurs on or after July 1 of any year, following completion of the year in which
the Date of Termination occurs, a pro rata portion, based on the number of days elapsed from the beginning of such year to the Date of Termination, of Executive’s bonus, if any, 

  
 4 

 
that would otherwise be payable with respect to such year under Section 2(b) above (based on actual performance for such year), payable on the date on which annual bonuses are paid generally by
the Company to its senior executives with respect to the year in which the Date of Termination occurs, but in all events during the calendar year immediately following the year in which the Date of Termination occurs; 

(C) accelerated vesting of any shares subject to outstanding equity incentive awards then-held by Executive that would, absent
Executive’s termination, otherwise vest during the twelve (12)-month period immediately following the Date of Termination based solely on continued employment or service during such period, effective as of the date on which the Release becomes
effective and irrevocable (with such shares remaining outstanding and eligible to vest if the Release becomes effective and irrevocable); and 

(D) if Executive elects to receive continued medical, dental or vision coverage under one or more of the Company’s group
healthcare plans pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), the Company shall directly pay, or reimburse Executive for, the COBRA premiums for Executive and Executive’s covered
dependents under such plans during the period commencing on Executive’s Separation from Service and ending upon the earliest of (X) the last day of the Severance Period, (Y) the date that Executive and/or Executive’s covered
dependents become no longer eligible for COBRA, or (Z) the date Executive becomes eligible to receive healthcare coverage from a subsequent employer. Notwithstanding the foregoing, if the Company determines in its sole discretion that it cannot
provide the foregoing benefit without potentially violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Company shall in lieu thereof provide to Executive a gross monthly payment in an
amount to cover the full monthly COBRA premium that Executive would be required to pay to continue Executive’s and Executive’s covered dependent’s group health coverage in effect on the Date of Termination (which amount shall be based
on the premium for the first month of COBRA coverage), which payments shall be made regardless of whether Executive elects COBRA continuation coverage and shall commence in the month following the month in which the Date of Termination occurs and
shall end on the earlier of (X) the last day of the Severance Period, (Y) the date that Executive or Executive’s covered dependents become no longer eligible for COBRA or (Z) the date Executive becomes eligible to receive
healthcare coverage from a subsequent employer. 
 (c) Survival. Notwithstanding anything to the contrary in this Agreement, the
provisions of Sections 5 through 9 and Section 11 will survive the termination of Executive’s employment and the expiration or termination of the Term. 

5. Solicitation. Executive acknowledges that the Company has provided and, during the Term, the Company from time to time will
continue to provide Executive with access to its Confidential Information (as defined below). Ancillary to the rights provided to Executive as set forth in this Agreement and the Company’s provision of Confidential Information, and
Executive’s agreements regarding the use of same, in order to protect the value of any Confidential Information, the Company and Executive agree to the following provisions, which Executive acknowledges represent a fair balance of the
Company’s rights to protect its business and Executive’s right to pursue employment: 

  
 5 

 (a) Executive shall not, at any time during the Restriction Period, directly or indirectly,
either for Executive or for any other person or entity, recruit or otherwise solicit or induce any employee or consultant of the Company to terminate his or her employment with the Company, other than through a general solicitation not targeting the
employees of the Company. 
 (b) In the event the terms of this Section 5 shall be determined by any court of
competent jurisdiction to be unenforceable by reason of its extending for too great a period of time or over too great a geographical area or by reason of its being too extensive in any other respect, it will be interpreted to extend only over the
maximum period of time for which it may be enforceable, over the maximum geographical area as to which it may be enforceable, or to the maximum extent in all other respects as to which it may be enforceable, all as determined by such court in such
action. 
 (c) As used in this Section 5, (i) the term “Company” shall include the
Company, Parent and all current and future, direct and indirect, subsidiaries of Parent; and (ii) the term “Restriction Period” shall mean the period beginning on the Effective Date and ending on the date twelve
(12) months following the Date of Termination. 
 (d) Each of the Parties (which, in the case of the Company, shall mean its officers
and the members of the Board) agrees, during the Term and following the Date of Termination, to refrain from Disparaging (as defined below) the other Party and its affiliates, including, in the case of the Company, any of its services, technologies
or practices, or any of its directors, officers, agents, representatives or stockholders, either orally or in writing. Nothing in this paragraph shall preclude any Party from making truthful statements that are reasonably necessary to comply with
applicable law, regulation or legal process, or to defend or enforce a Party’s rights under this Agreement. For purposes of this Agreement, “Disparaging” means remarks, comments or statements, whether written or oral, that impugn the
character, integrity, reputation or abilities of the Person being disparaged. 
 (e) Executive represents that Executive’s employment by
the Company does not and will not breach any agreement with any former employer, including any non-compete agreement or any agreement to keep in confidence or refrain from using information acquired by
Executive prior to Executive’s employment by the Company. During Executive’s employment by the Company, Executive agrees that Executive will not violate any non-solicitation agreements Executive
entered into with any former employer or improperly make use of, or disclose, any information or trade secrets of any former employer or other third party, nor will Executive bring onto the premises of the Company or use any unpublished documents or
any property belonging to any former employer or other third party, in violation of any lawful agreements with that former employer or third party. 
 6.
Nondisclosure of Proprietary Information. 
 (a) Except in connection with the faithful performance of Executive’s duties
hereunder or pursuant to Section 6(c) and (e), Executive shall, in perpetuity, maintain in confidence and shall not directly, indirectly or otherwise, use, disseminate, disclose or publish, or use for
Executive’s benefit or the benefit of any person, firm, corporation or other entity (other than the Company and its affiliates) any confidential or proprietary information or trade secrets of or relating to the Company (including, without
limitation, business plans, business strategies and methods, acquisition targets, intellectual property in the form of patents, trademarks and copyrights and applications therefor, ideas, inventions, works, discoveries, improvements, information,
documents, formulae, practices, processes, methods, developments, source code, modifications, technology, techniques, data, programs, other know-how or materials, owned, developed or possessed by the Company,
whether in tangible or intangible form, information with respect to the Company’s operations, processes, products, inventions, business practices, finances, principals, vendors, suppliers, customers, potential customers, marketing methods,
costs, prices, 

  
 6 

 
contractual relationships, regulatory status, prospects and compensation paid to employees or other terms of employment) (collectively, the “Confidential Information”), or
deliver to any person, firm, corporation or other entity any document, record, notebook, computer program or similar repository of or containing any such Confidential Information. The Parties hereby stipulate and agree that, as between them, any
item of Confidential Information is important, material and confidential and affects the successful conduct of the businesses of the Company (and any successor or assignee of the Company). Notwithstanding the foregoing, Confidential Information
shall not include any information that has been published in a form generally available to the public or is publicly available or has become public knowledge prior to the date Executive proposes to disclose or use such information, provided,
that such publishing or public availability or knowledge of the Confidential Information shall not have resulted from Executive directly or indirectly breaching Executive’s obligations under this Section 6(a) or any other similar
provision by which Executive is bound, or from any third-party breaching a provision similar to that found under this Section 6(a). For the purposes of the previous sentence, Confidential Information will not be deemed to have been published
or otherwise disclosed merely because individual portions of the information have been separately published, but only if material features comprising such information have been published or become publicly available. 

(b) Upon termination of Executive’s employment with the Company for any reason, Executive will promptly deliver to the Company all
correspondence, drawings, manuals, letters, notes, notebooks, reports, programs, plans, proposals, financial documents, or any other documents or property concerning the Company’s customers, business plans, marketing strategies, products,
property or processes. 
 (c) Executive may respond to a lawful and valid subpoena or other legal process but shall give the Company the
earliest possible notice thereof, shall, as much in advance of the return date as possible, make available to the Company and its counsel the documents and other information sought and shall assist such counsel at Company’s expense in resisting
or otherwise responding to such process, in each case to the extent permitted by applicable laws or rules. 
 (d) As used in this
Section 6 and Section 7, the term “Company” shall include the Company and its direct and indirect parents and subsidiaries. 

(e) Nothing in this Agreement is intended to or shall be used in any way to: (i) limit Executive from disclosing information and documents
when required by law, subpoena or court order (subject to the requirements of Section 6(c) above), (ii) limit Executive’s rights to communicate with a government agency, as provided for, protected under or warranted by applicable law,
(iii) prohibit Executive from disclosing information and documents to Executive’s attorney, financial or tax adviser for the purpose of securing legal, financial or tax advice, (iv) prohibit Executive from disclosing Executive’s
post-employment restrictions in this Agreement in confidence to any potential new employer, or (v) prohibit Executive from retaining, at any time, Executive’s personal correspondence, Executive’s personal contacts and documents
related to Executive’s own personal benefits, entitlements and obligations. In addition, Executive may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of Confidential Information that:
(x) is made (1) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (2) solely for the purpose of reporting or investigating a suspected violation of law; or
(y) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. 

  
 7 

 7. Inventions. 

All rights to discoveries, inventions, improvements and innovations (including all data and records pertaining thereto) related to the business
of the Company, whether or not patentable, copyrightable, registrable as a trademark, or reduced to writing, that Executive may discover, invent or originate during the Term, either alone or with others and whether or not during working hours or by
the use of the facilities of the Company, but only to the extent allowed by California Labor Code Section 2870 (which is attached hereto as Appendix A) (“Inventions”), shall be the exclusive property of the Company.
Executive shall promptly disclose all Inventions to the Company, shall execute at the request of the Company any assignments or other documents the Company may deem reasonably necessary to protect or perfect its rights therein, and shall assist the
Company, upon reasonable request and at the Company’s expense, in obtaining, defending and enforcing the Company’s rights therein. Executive hereby appoints the Company as Executive’s attorney-in-fact to execute on Executive’s behalf any assignments or other documents reasonably deemed necessary by the Company to protect or perfect its rights to any Inventions. 

8. Injunctive Relief. 
 It is
recognized and acknowledged by Executive that a breach of the covenants contained in Sections 5, 6 and 7 will cause irreparable damage to Company and its goodwill, the exact amount of which will be difficult or impossible to ascertain, and
that the remedies at law for any such breach will be inadequate. Accordingly, Executive agrees that in the event of a breach of any of the covenants contained in Sections 5, 6 and 7, in addition to any other remedy which may be available at
law or in equity, the Company will be entitled to seek specific performance and injunctive relief. 
 9. Assignment and Successors. 

The Company may assign its rights and obligations under this Agreement to any successor to all or substantially all of the business or the
assets of the Company (by merger or otherwise), and may assign or encumber this Agreement and its rights hereunder as security for indebtedness of the Company and its affiliates. This Agreement shall be binding upon and inure to the benefit of the
Company, Executive and their respective successors, assigns, personnel and legal representatives, executors, administrators, heirs, distributees, devisees, and legatees, as applicable. None of Executive’s rights or obligations may be assigned
or transferred by Executive, other than Executive’s rights to payments hereunder, which may be transferred only by will or operation of law. Notwithstanding the foregoing, Executive shall be entitled, to the extent permitted under applicable
law and applicable Company Arrangements, to select and change a beneficiary or beneficiaries to receive compensation hereunder following Executive’s death by giving written notice thereof to the Company. 

10. Certain Definitions. 
 (a)
Cause. The Company shall have “Cause” to terminate Executive’s employment hereunder upon: 
 (i)
Executive’s failure to comply with, in any material respect, any of the material Company’s Policies; 
 (ii)
Executive’s failure in any material respect to carry out or comply with any lawful and reasonable directive of the Board; 

(iii) Executive’s breach of a material provision of this Agreement, any Restricted Stock Agreement and any other material
agreement among Executive and the Company, Parent or subsidiary thereof; 
 (iv) Executive’s commission of, conviction
of, or plea of “guilty” or “no contest” to, any felony or crime involving moral turpitude; 

  
 8 

 (v) Executive’s unlawful use (including being under the influence) or
possession of illegal drugs on Parent’s or its direct or indirect subsidiaries’ premises or while performing Executive’s duties and responsibilities under this Agreement; 

(vi) Executive’s willful, reckless or gross misconduct bringing Parent or its direct or indirect subsidiaries into any
public disgrace or disrepute; or 
 (vii) Executive’s commission of an act of dishonesty, disloyalty, fraud,
embezzlement, misappropriation, willful misconduct, or breach of fiduciary duty with respect to Parent or its direct or indirect subsidiaries. 

Notwithstanding the foregoing, in the case of clauses (i), (ii) and (iii) above, no “Cause” will have occurred unless and until
the Company has provided Executive with written notice of the circumstances setting forth the elements of “Cause” in reasonable detail and an opportunity to cure such finding of “Cause” within thirty (30) days after the
receipt of such notice. If the Executive fails to cure the same within such thirty (30) days, then “Cause” shall be deemed to have occurred as of the expiration of the 30-day cure period. In the
event that (a) Executive’s employment with the Company terminates for any reason other than for Cause (including, without limitation, whether by death, Disability, resignation or termination without Cause or with Good Reason) and
(b) any of the facts and circumstances described in (iv) through (vi) above existed as of the date of Executive’s termination (whether or not known by the Board as of the termination or discovered after any such termination), by a
vote of the Board, the Company may deem the termination of the Executive’s employment to have been for Cause and, for all purposes of this Agreement (including Sections 3 and 4), the termination shall be treated as a termination by the Company
for Cause and the Company and Executive shall have the corresponding rights or obligations associated with a termination for Cause. 
 (b)
Date of Termination. “Date of Termination” shall mean (i) if Executive’s employment is terminated by Executive’s death, the date of Executive’s death; or (ii) if Executive’s employment is
terminated pursuant to Section 3(a)(ii) – (vi) either the date indicated in the Notice of Termination or the date specified by the Company pursuant to Section 3(b), whichever is earlier. 

(c) Disability. “Disability” shall mean, at any time the Company or any of its affiliates sponsors a long-term
disability plan for the Company’s employees, “disability” as defined in such long-term disability plan for the purpose of determining a participant’s eligibility for benefits, provided, however, if the long-term disability plan
contains multiple definitions of disability, “Disability” shall refer to that definition of disability which, if Executive qualified for such disability benefits, would provide coverage for the longest period of time. The determination of
whether Executive has a Disability shall be made by the person or persons required to make disability determinations under the long-term disability plan. At any time the Company does not sponsor a long-term disability plan for its employees,
Disability shall mean Executive’s inability to perform, with or without reasonable accommodation, the essential functions of Executive’s position hereunder for a total of three months during any six-
(6-) month period as a result of incapacity due to mental or physical illness as determined by a physician selected by the Company or its insurers and acceptable to Executive or Executive’s legal
representative, with such agreement as to acceptability not to be unreasonably withheld or delayed. Any refusal by Executive to submit to a medical examination for the purpose of determining Disability shall be deemed to constitute conclusive
evidence of Executive’s Disability. 

  
 9 

 (d) Good Reason. For the sole purpose of determining Executive’s right to severance
payments as described above, the Executive’s resignation will be for “Good Reason” if the Executive resigns within ninety (90) days after any of the following events, unless Executive consents in writing to the applicable
event: (i) a material decrease in Executive’s annual base salary or bonus opportunity, other than a reduction in annual base salary of less than ten percent (10%) that is implemented in connection with a contemporaneous reduction in annual
base salaries affecting all other senior executives of the Company, or the Company’s material failure to pay any compensation due to Executive when due and payable or other breach of a material provision of this Agreement, (ii) a material
decrease in the Executive’s authority or areas of responsibility as are commensurate with such Executive’s title or position (other than in connection with a corporate transaction where the Executive continues to hold the position
referenced in Section 1(c) above with respect to the Company’s business, substantially as such business exists prior to the date of consummation of such corporate transaction, but does not hold such position with respect to the successor
corporation), or (iii) the relocation of the Executive’s primary office to a location more than twenty-five (25) miles from the Company’s headquarters at 2217 Main Street Santa Monica, California 90405. Notwithstanding the
foregoing, no Good Reason will have occurred unless and until Executive has: (a) provided the Company, within sixty (60) days of Executive’s knowledge of the occurrence of the facts and circumstances underlying the Good Reason event,
written-notice stating with specificity the applicable facts and circumstances underlying such finding of Good Reason; and (b) provided the Company with an opportunity to cure the same within thirty (30) days after the receipt of such
notice. 
 (e) Person. “Person” shall mean any individual, firm, corporation, partnership, limited liability company,
incorporated or unincorporated association, joint venture, joint stock company, trust, governmental authority or other entity of any kind. 
 11.
Miscellaneous Provisions. 
 (a) Governing Law. This Agreement shall be governed, construed, interpreted and enforced in
accordance with its express terms, and otherwise in accordance with the substantive laws of the State of California without reference to the principles of conflicts of law of the State of California or any other jurisdiction, and where applicable,
the laws of the United States. 
 (b) Validity. The invalidity or unenforceability of any provision or provisions of this Agreement
shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect. 
 (c)
Notices. Any notice, request, claim, demand, document and other communication hereunder to any Party shall be effective upon receipt (or refusal of receipt) and shall be in writing and delivered personally or sent by facsimile or certified or
registered mail, postage prepaid, as follows: 
  

	 	(i)	If to the Company: 

 YWX Holdings, Inc. 

c/o Great Hill Partners LLC 

One Liberty Square 

Boston, MA 02109 

Attention: Laurie Gerber 

Facsimile: (617) 292-9430 

E-mail address: lgerber@greathillpartners.com 

with a copy to: 

  
 10 

 Latham & Watkins, LLP 

John Hancock Tower 

200 Clarendon Street 

Boston, MA 02116 

Attention: Alexander B. Temel 

Facsimile: (617) 948-6001 

E-mail address: alexander.temel@lw.com 

If to Executive, at the last address that the Company has in its personnel records for Executive, 

or at any other address as any Party shall have specified by notice in writing to the other Party. 

(d) Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of
which together will constitute one and the same Agreement. Signatures delivered by facsimile or other electronic delivery method shall be deemed effective for all purposes. 

(e) Entire Agreement. The terms of this Agreement are intended by the Parties to be the final expression of their agreement with respect
to the employment of Executive by the Company and supersede all prior understandings and agreements, whether written or oral, including, without limitation, that certain Employment Agreement between the Parties dated
January         , 2015. The Parties further intend that this Agreement shall constitute the complete and exclusive statement of their terms and that no extrinsic evidence whatsoever may be introduced in any
judicial, administrative, or other legal proceeding to vary the terms of this Agreement. 
 (f) Amendments: Waivers. This Agreement
may not be modified, amended, or terminated except by an instrument in writing, signed by Executive and a duly authorized officer of Company. By an instrument in writing similarly executed, Executive or a duly authorized officer of the Company may
waive compliance by the other Party with any specifically identified provision of this Agreement that such other Party was or is obligated to comply with or perform; provided, however, that such waiver shall not operate as a waiver of, or
estoppel with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder preclude any other or further exercise of any other right, remedy, or power provided herein or by law
or in equity. 
 (g) No Inconsistent Actions. The Parties hereto shall not voluntarily undertake or fail to undertake any action or
course of action inconsistent with the provisions or essential intent of this Agreement. Furthermore, it is the intent of the Parties hereto to act in a fair and reasonable manner with respect to the interpretation and application of the provisions
of this Agreement. 
 (h) Construction. This Agreement shall be deemed drafted equally by both of the Parties. Its language shall be
construed as a whole and according to its fair meaning. Any presumption or principle that the language is to be construed against any Party shall not apply. The headings in this Agreement are only for convenience and are not intended to affect
construction or interpretation. Any references to paragraphs, subparagraphs, sections or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary. Also, unless the context clearly indicates to the
contrary, (a) the plural includes the singular and the singular includes the plural; (b) “and” and “or” are each used both conjunctively and disjunctively; (c) “any,” “all,” “each,” or
“every” means “any and all,” and “each and every”; (d) “includes” and “including” are each “without limitation”; (e) “herein,” “hereof,” “hereunder” and other
similar compounds of the word “here” refer to the entire Agreement and not to any particular paragraph, subparagraph, section or subsection; and (f) all pronouns and any variations thereof shall be deemed to refer to the masculine,
feminine, neuter, singular or plural as the identity of the entities or persons referred to may require. 

  
 11 

 (i) Arbitration. Any controversy, claim or dispute arising out of or relating to this
Agreement, shall be settled solely and exclusively by a binding arbitration process administered by JAMS in Los Angeles, California. Such arbitration shall be conducted in accordance with the then-existing JAMS Employment Rules and Procedures, with
the following exceptions if in conflict: (a) one arbitrator who is a retired judge shall be chosen by JAMS; (b) the Company will pay the expenses and fees of the arbitrator, together with other expenses of the arbitration incurred or
approved by the arbitrator; and (c) arbitration may proceed in the absence of any Party if written notice (pursuant to the JAMS rules and regulations) of the proceedings has been given to such Party. Each Party shall bear its own attorneys fees
and expenses; provided that the arbitrator may assess the prevailing Party’s fees and costs against the non-prevailing Party as part of the arbitrator’s award if provided and allowed by law. The
Parties agree to abide by all decisions and awards rendered in such proceedings. Such decisions and awards rendered by the arbitrator shall be final and conclusive. All such controversies, claims or disputes shall be settled in this manner in lieu
of any action at law or equity; provided, however, that nothing in this subsection shall be construed as precluding the bringing an action for injunctive relief or specific performance as provided in this Agreement. This dispute resolution process
and any arbitration hereunder shall be confidential and neither any Party nor the neutral arbitrator shall disclose the existence, contents or results of such process without the prior written consent of all Parties, except where necessary or
compelled in a Court to enforce this arbitration provision or an Award from such arbitration or otherwise in a legal proceeding. If JAMS no longer exists or is otherwise unavailable, the Parties agree that the American Arbitration Association
(“AAA”) shall administer the arbitration in accordance with its then-existing rules. In such event, all references herein to JAMS shall mean AAA. Notwithstanding the foregoing, Executive and the Company each have the right to
resolve any issue or dispute over intellectual property rights by Court action instead of arbitration. Executive and the Company understand that by agreeing to arbitration any claim pursuant to this Section 11(i), they will not have the right to
have any such claim decided by a jury or a court, but shall instead have any such claim decided through arbitration. Executive and the Company waive any constitutional or other right to bring claims covered by this Agreement other than in their
individual capacities. Except as may be prohibited by law, this waiver includes the ability to assert claims as a plaintiff or class member in any purported class or representative proceeding. 

(j) Enforcement. If any provision of this Agreement is held to be illegal, invalid or unenforceable under present or future laws
effective during the term of this Agreement, such provision shall be fully severable; this Agreement shall be construed and enforced as if such illegal, invalid or unenforceable provision had never comprised a portion of this Agreement; and the
remaining provisions of this Agreement shall remain in full force and effect and shall not be affected by the illegal, invalid or unenforceable provision or by its severance from this Agreement. Furthermore, in lieu of such illegal, invalid or
unenforceable provision there shall be added automatically as part of this Agreement a provision as similar in terms to such illegal, invalid or unenforceable provision as may be possible and be legal, valid and enforceable. 

(k) Withholding. The Company shall be entitled to withhold from any amounts payable under this Agreement any federal, state, local or
foreign withholding or other taxes or charges which the Company is required to withhold. The Company shall be entitled to rely on an opinion of counsel if any questions as to the amount or requirement of withholding shall arise. 

  
 12 

 (l) Section 409A. 

(i) General. The intent of the Parties is that the payments and benefits under this Agreement comply with or be exempt
from Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder (collectively, “Section 409A”) and, accordingly, to the maximum extent permitted, this Agreement shall be
interpreted to be in compliance therewith. 
 (ii) Separation from Service. Notwithstanding anything in this Agreement
to the contrary, any compensation or benefits payable under this Agreement that is designated under this Agreement as payable upon Executive’s termination of employment shall be payable only upon Executive’s “separation from
service” with the Company within the meaning of Section 409A (a “Separation from Service”) and, except as provided below, any such compensation or benefits shall not be paid, or, in the case of installments, shall not commence
payment, until the sixtieth (60th) day following Executive’s Separation from Service. Any installment payments that would have been made to Executive during the sixty (60) day period immediately following Executive’s Separation from
Service but for the preceding sentence shall be paid to Executive on the sixtieth (60th) day following Executive’s Separation from Service and the remaining payments shall be made as provided in this Agreement. 

(iii) Specified Employee. Notwithstanding anything in this Agreement to the contrary, if Executive is deemed by the
Company at the time of Executive’s Separation from Service to be a “specified employee” for purposes of Section 409A, to the extent delayed commencement of any portion of the benefits to which Executive is entitled under this
Agreement is required in order to avoid a prohibited distribution under Section 409A, such portion of Executive’s benefits shall not be provided to Executive prior to the earlier of (i) the expiration of the
six-month period measured from the date of Executive’s Separation from Service with the Company or (ii) the date of Executive’s death. Upon the first business day following the expiration of the
applicable Section 409A period, all payments deferred pursuant to the preceding sentence shall be paid in a lump sum to Executive (or Executive’s estate or beneficiaries), and any remaining payments due to Executive under this Agreement shall
be paid as otherwise provided herein. 
 (iv) Expense Reimbursements. To the extent that any reimbursements under this
Agreement are subject to Section 409A, any such reimbursements payable to Executive shall be paid to Executive no later than December 31 of the year following the year in which the expense was incurred; provided, that Executive submits
Executive’s reimbursement request promptly following the date the expense is incurred, the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year, other than medical expenses
referred to in Section 105(b) of the Code, and Executive’s right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit. 

(v) Installments. Executive’s right to receive any installment payments under this Agreement, including without
limitation any continuation salary payments that are payable on Company payroll dates, shall be treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at all times be considered a separate
and distinct payment as permitted under Section 409A. Except as otherwise permitted under Section 409A, no payment hereunder shall be accelerated or deferred unless such acceleration or deferral would not result in additional tax or interest
pursuant to Section 409A. 

  
 13 

 12. Employee Acknowledgement. 

Executive acknowledges that Executive has read and understands this Agreement, is fully aware of its legal effect, has not acted in reliance
upon any representations or promises made by the Company other than those contained in writing herein, and has entered into this Agreement freely based on Executive’s own judgment. 

[Signature Page Follows] 

  
 14 

 IN WITNESS WHEREOF, the Parties have executed this Agreement on the date and year first above
written. 
  

			
	COMPANY
		
	By:	 	 /s/ Kurt Donnell

		 	 Name: Kurt Donnell

		 	 Title: Secretary

	
	EXECUTIVE
		
	By:	 	 /s/ Rosanna McCollough

		 	 Rosanna McCollough

  
 [Signature Page to
Employment Agreement] 

 EXHIBIT A 

Separation Agreement and Release 

This Separation Agreement and Release (“Agreement”) is made by and between Rosanna McCollough
(“Employee”) and Whole Body, Inc. (the “Company”) (collectively, referred to as the “Parties” or individually referred to as a “Party”). Capitalized terms used but not defined in
this Agreement shall have the meanings set forth in the Employment Agreement (as defined below). 
 WHEREAS, the Parties have previously
entered into that certain Employment Agreement, dated as of                     , 2017 (the “Employment Agreement”); and 

WHEREAS, in connection with the Employee’s termination of employment with the Company or a subsidiary or affiliate of the Company
effective                    , 20    , the Parties wish to resolve any and all disputes, claims, complaints, grievances, charges,
actions, petitions, and demands that the Employee may have against the Company and any of the Releasees as defined below, including, but not limited to, any and all claims arising out of or in any way related to Employee’s employment with or
separation from the Company or its subsidiaries or affiliates but, for the avoidance of doubt, nothing herein will be deemed to release any rights or remedies in connection with Employee’s ownership of vested equity securities of the Company or
Employee’s right to indemnification by the Company or any of its affiliates pursuant to contract or applicable law (collectively, the “Retained Claims”). 

NOW, THEREFORE, in consideration of the Severance Payments described in Section 4 of the Employment Agreement, which, pursuant to the
Employment Agreement, are conditioned on the Employee’s execution and non-revocation of this Agreement, and in consideration of the mutual promises made herein, the Company and Employee hereby agree as
follows: 
 1. Severance Payments; Salary and Benefits. The Company agrees to provide Employee with the severance payments and
benefits described in Section 4(b) of the Employment Agreement, payable at the times set forth in, and subject to the terms and conditions of, the Employment Agreement. In addition, to the extent not already paid, and subject to the terms and
conditions of the Employment Agreement, the Company shall pay or provide to the Employee all other payments or benefits described in Section 3(c) of the Employment Agreement, subject to and in accordance with the terms thereof. 

2. Release of Claims. Employee agrees that, other than with respect to the Retained Claims, the foregoing consideration/severance
payments represent settlement in full of all outstanding obligations owed to Employee by the Company, Parent (as defined in the Employment Agreement), any of their direct or indirect subsidiaries and affiliates, and any of their current and former
officers, directors, equity holders, managers, employees, agents, investors, attorneys, shareholders, administrators, affiliates, benefit plans, plan administrators, insurers, trustees, divisions, and subsidiaries and predecessor and successor
corporations and assigns (collectively, the “Releasees”). Employee, on his own behalf and on behalf of any of Employee’s affiliated companies or entities and any of their respective heirs, family members, executors, agents, and
assigns, other than with respect to the Retained Claims, hereby and forever releases the Releasees from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, or cause
of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Employee may possess against any of the Releasees arising from any omissions, acts, facts, or damages that have occurred up until and
including the Effective Date of this Agreement (as defined in Section 7 below), including, without limitation: 
 (a) any and all claims
relating to or arising from Employee’s employment or service relationship with the Company or any of its direct or indirect subsidiaries or affiliates and the termination of that relationship; 

  
 16 

 (b) any and all claims relating to, or arising from, Employee’s right to purchase, or actual
purchase of any shares of stock or other equity interests of the Company or any of its affiliates, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law,
and securities fraud under any state or federal law; 
 (c) any and all claims for wrongful discharge of employment; termination in violation
of public policy; discrimination; harassment; retaliation; breach of contract, both express and implied; breach of covenant of good faith and fair dealing, both express and implied; promissory estoppel; negligent or intentional infliction of
emotional distress; fraud; negligent or intentional misrepresentation; negligent or intentional interference with contract or prospective economic advantage; unfair business practices; defamation; libel; slander; negligence; personal injury;
assault; battery; invasion of privacy; false imprisonment; conversion; and disability benefits; 
 (d) any and all claims for violation of
any federal, state, or municipal statute, including, but not limited to, [Title VII of the Civil Rights Act of 1964; the Civil Rights Act of 1991; the Rehabilitation Act of 1973; the Americans with Disabilities Act of 1990; the Equal Pay Act; the
Fair Credit Reporting Act; the Age Discrimination in Employment Act of 1967; the Older Workers Benefit Protection Act; the Employee Retirement Income Security Act of 1974; the Worker Adjustment and Retraining Notification Act; the Family and Medical
Leave Act; the California Fair Employment and Housing Act; the California Equal Pay Law; the Moore-Brown-Roberti Family Rights Act of 1991; the California Labor Code; the California WARN Act; the California False Claims Act; and the California
Corporate Criminal Liability Act]*; 
 (e) any and all claims for violation of the federal or any state constitution; 

(f) any and all claims arising out of any other laws and regulations relating to employment or employment discrimination; 

(g) any claim for any loss, cost, damage, or expense arising out of any dispute over the
non-withholding or other tax treatment of any of the proceeds received by Employee as a result of this Agreement; and 

(h) any and all claims for attorneys’ fees and costs. 

Employee agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters
released. This release does not release claims that cannot be released as a matter of law, including, but not limited to, Employee’s right to file a charge with or participate in a charge by the Equal Employment Opportunity Commission, or any
other local, state, or federal administrative body or government agency that is authorized to enforce or administer laws related to employment, against the Company (with the understanding that Employee’s release of claims herein bars Employee
from recovering such monetary relief from the Company or any Releasee), claims for unemployment compensation or any state disability insurance benefits pursuant to the terms of applicable state law, claims to continued participation in certain of
the Company’s group benefit plans pursuant to the terms and conditions of COBRA, claims to any benefit entitlements vested as the date of separation of Employee’s employment, pursuant to written terms of any employee benefit plan of the
Company or its affiliates and Employee’s right under applicable law and any Retained Claims. This release further does not release claims for breach of Section 3(c) or Section 4(b) of the Employment Agreement. 

 

	* 	Subject to confirmation. 

  
 17 

 In addition, nothing in this Release precludes Executive from participating in any investigation or proceeding
before any federal or state agency, or governmental body, including, but not limited to, the Equal Employment Opportunity Commission, the Securities and Exchange Commission and/or the Department of Justice. 

3. Acknowledgment of Waiver of Claims under ADEA. Employee understands and acknowledges that she is waiving and releasing any rights she
may have under the Age Discrimination in Employment Act of 1967 (“ADEA”), and that this waiver and release is knowing and voluntary. Employee understands and agrees that this waiver and release does not apply to any rights or claims
that may arise under the ADEA after the Effective Date of this Agreement. Employee understands and acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Employee was already entitled.
Employee further understands and acknowledges that she has been advised by this writing that: (a) she should consult with an attorney prior to executing this Agreement; (b) she has [twenty-one (21)]† days within which to consider this Agreement; (c) she has 7 days following his execution of this Agreement to revoke this
Agreement pursuant to written notice to the                     of the Company; (d) this Agreement shall not be effective until after the revocation
period has expired; and (e) nothing in this Agreement prevents or precludes Employee from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties,
or costs for doing so, unless specifically authorized by federal law. In the event Employee signs this Agreement and returns it to the Company in less than the [twenty-one (21)] day period identified above,
Employee hereby acknowledges that she has freely and voluntarily chosen to waive the time period allotted for considering this Agreement. 

4. Severability. In the event that any provision or any portion of any provision hereof or any surviving agreement made a part hereof
becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Agreement shall continue in full force and effect without said provision or portion of provision. 

5. No Oral Modification. This Agreement may only be amended in a writing signed by Employee and a duly authorized officer of the
Company. 
 6. Governing Law; Dispute Resolution. This Agreement shall be subject to the provisions of Sections 11(a), 11(c) and 11(i)
of the Employment Agreement. 
 7. Effective Date. If the Employee has attained or is over the age of 40 as of the date of
Employee’s termination of employment, then Employee has seven days after signing this Agreement to revoke it and this Agreement will become effective on the eighth day after Employee signed this Agreement, so long as it has been signed by the
Parties and has not been revoked by Employee before that date (the “Effective Date”). If the Employee has not attained the age of 40 as of the date of Employee’s termination of employment, then the “Effective Date”
shall be the date on which Employee signs this Agreement. 
 8. Voluntary Execution of Agreement. Employee understands and agrees that
she executed this Agreement voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of his claims against the Company and any of the other Releasees. Employee
acknowledges that: (a) she has read this Agreement; (b) she has not relied upon any representations or statements made by the Company that are not specifically set forth in this Agreement; (c) she has been represented in the
preparation, negotiation, and execution of this Agreement by legal counsel of his own choice or has elected not to retain legal counsel; (d) she understands the terms and consequences of this Agreement and of the releases it contains; and
(e) she is fully aware of the legal and binding effect of this Agreement. 
  

	†	45 days to the extent required by applicable law. 

  
 18 

 IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth
below. 
  

							
	Dated:                     	 		 		 	  

		 		 		 	[                            ]
				
		 		 		 	COMPANY
				
	Dated:                    	 		 		 	By:
                                         
   
		 		 		 	       Name:
		 		 		 	       Title:

 Appendix A 

California Labor Code Section 2870. Application of provision providing that employee shall assign or offer to assign rights in
invention to employer. 
 (i) Any provision in an employment agreement which provides that an employee shall assign, or
offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer’s equipment, supplies, facilities, or trade
secret information except for those inventions that either: 
 (A) Relate at the time of conception or reduction to practice
of the invention to the employer’s business, or actual or demonstrably anticipated research or development of the employer; or 

(B) Result from any work performed by the employee for his employer. 

To the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from being required to be
assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable. 

  
 21

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}]]